The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSA nadir–stratified outcomes of ARPI doublet and docetaxel triplet therapy in metastatic prostate cancer.
 
Miguel Zugman
Consulting or Advisory Role - Eisai
Research Funding - 2025 KCA Traiblazer Award/Kure It Cancer Research
 
Jennifer Rider
Expert Testimony - Bayer/Monsanto
 
Ryan Pindale
No Relationships to Disclose
 
Koral Shah
No Relationships to Disclose
 
Ali Moradi
No Relationships to Disclose
 
Salvador Jaime-Casas
No Relationships to Disclose
 
Peter Zang
No Relationships to Disclose
 
Nicholas Salgia
No Relationships to Disclose
 
Vitor Abreu De Goes
No Relationships to Disclose
 
Diwyanshu Sahu
No Relationships to Disclose
 
Hedyeh Ebrahimi
No Relationships to Disclose
 
Regina Barragan-Carrillo
Honoraria - Astellas Pharma; Ipsen; Merck; MSD; Pfizer
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Nazli Dizman
Stock and Other Ownership Interests - Several pharmaceutical companies (I)
Consulting or Advisory Role - Eisai
 
Joann Hsu
No Relationships to Disclose
 
Wesley Yip
Consulting or Advisory Role - Ferring; Gilead Sciences; SAI MedPartners; Telix Pharmaceuticals
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Formedics
 
Charles Nguyen
Honoraria - MJH Associates
Consulting or Advisory Role - Dendreon; Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - DAVA Oncology
 
Alex Chehrazi-Raffle
Honoraria - ASCO; EPG Health; Medical Oncology Association of Southern California; OncLive/MJH Life Sciences
Consulting or Advisory Role - Aveo Inc; Eisai; Exelixis; Seagen
Speakers' Bureau - Exelixis
Research Funding - Exelixis
Travel, Accommodations, Expenses - Bayer
 
Sumanta Pal
Speakers' Bureau - IntrinsiQ; MJH Life Sciences; Peerview
Research Funding - Adicet Bio (Inst); Adicet Bio (Inst); ArsenalBio (Inst); crispr therapeutics (Inst); Exelixis (Inst); Genentech (Inst); Merck (Inst); Miyarisan pharmaceutical (Inst); Osel (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - crispr therapeutics; Exelixis; Ipsen
 
Tanya Dorff
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Novartis; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Hookipa Biotech (Inst); Janssen Oncology (Inst); Promontory Therapeutics (Inst)